2m 2m 2m 2m 2m 2m 2m
Kura Oncology (KURA)
NASDAQ
$11.89$0.00 (0.00%)
Price as of Aug 21, 2026 7:54 PM EDT- $1.1BMarket Cap
- 55.42%1-Year Change
- BiotechnologyIndustry
Kura Oncology (KURA)
$11.89$0.00 (0.00%)
KURA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.89 | ||
Change | +$0.18 (+1.54%) | ||
Open | $11.78 | ||
High | $12.25 | ||
Low | $11.67 | ||
Previous Close | $11.71 | ||
Volume | 2,027,522 | ||
30-Day Average Volume | 1,709,036 | ||
1-Week Change | 9.48% | ||
1-Month Change | 9.18% | ||
1-Year Change | 55.42% | ||
3-Year Change | 8.88% | ||
5-Year Change | -25.22% | ||
Fundamentals | |||
Shares Outstanding | 89.0M | ||
Total Assets | $587.8M | ||
Market Cap | $1.1B | ||
Enterprise Value | $997.3M | ||
Period: QTR TTM FY | |||
Revenue | $9.1M | ||
Net Income | -$68.3M | ||
Free Cash Flow | -$63.2M | ||
EBIT | -$68.3M | ||
EBITDA | -$68.0M | ||
Net Working Capital | $441.2M | ||
EPS | -$0.77 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 109 | ||
P/B | 22 | ||
P/E | -15 | ||
PEG | -2 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue